Revisiting the role of civil society in responses to infectious disease outbreaks: a proposed framework and lessons from a COVID-19 vaccine equity coalition in Uganda

Hossain, Azfar D; Nakalule, Mastulah; Venkataraman, Shreenithi; Guillaume, Yodeline; Mohareb, Amir M; Wandera, Dennis Nelson; Joan, Kilande Esther; Hasunira, Richard; Abenaitwe, Cliff; Stuart, Ssebibubbu; Mwehonge, Kenneth; Asiimwe, Stephen; Ivers, Louise C

doi:10.1136/bmjgh-2023-012510

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An ongoing global advocacy strategy by Global South governments, CSOs and multilateral and bilateral organisations pressuring the Global North to engage in improved global vaccine equity is needed. CSOs in the Global South, such as People’s Vaccine Alliance, and the Vaccine Advocacy Accelerator have started to mobilise 46 47. A model for global vaccine advocacy could be based on what has been accomplished for HIV.…”

Section: Our Proposalmentioning

confidence: 99%

See 1 more Smart Citation

Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics

Martin,

Maleche,

Gay

et al. 2024

BMJ Glob Health

View full text Add to dashboard Cite

COVID-19, which killed more than 6 million people, will not be the last pandemic. Vaccines are key to preventing and ending pandemics. Therefore, it is critical to move now, before the next pandemic, towards global vaccine equity with shared goals, intermediate steps and long-term advocacy goals. Scientific integrity, ethical development, transparency, accountability and communication are critical. Countries can draw on lessons learnt from their response to the HIV pandemics, which has been at the vanguard of ensuring equitable access to rights-based services, to create shared goals and engage communities to increase access to and delivery of safe, quality vaccines. Access can be increased by: fostering the spread of mRNA intellectual property (IP) rights, with mRNA vaccine manufacturing on more continents; creating price transparency for vaccines; creating easily understandable, accessible and transparent data on vaccines; creating demand for a new international legal framework that allows IP rights to be waived quickly once a global pandemic is identified; and drawing on scientific expertise from around the world. Delivery can be improved by: creating strong public health systems that can deliver vaccines through the lifespan; creating or strengthening national regulatory agencies and independent national scientific advisory committees for vaccines; disseminating information from reliable, transparent national and subnational surveillance systems; improving global understanding that as more scientific data become available, this may result in changes to public health guidance; prioritising access to vaccines based on scientific criteria during an epidemic; and developing strategies to vaccinate those at highest risk with available vaccines.

show abstract

Section: Our Proposalmentioning

confidence: 99%

“…CSOs in the Global South, such as People's Vaccine Alliance, and the Vaccine Advocacy Accelerator have started to mobilise. 46 47 A model for global vaccine advocacy could be based on what has been accomplished for HIV. One of the lessons from the global AIDS pandemic is that public advocacy leads to results.…”

Section: Bmj Global Healthmentioning

confidence: 99%

Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics

Martin,

Maleche,

Gay

et al. 2024

BMJ Glob Health

View full text Add to dashboard Cite

show abstract

“…Civil society: It helps the health system to connect with difficult-to-reach or vulnerable populations, supplementing government emergency aid response, and delivering necessary resources (102)(103)(104).…”

Section: How Does Universal Health Coverage Work?mentioning

confidence: 99%

Universal Health Coverage – Exploring the What, How, and Why Using Realistic Review

Endalamaw,

Mengistu,

Khatri

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Universal health coverage (UHC) is a critical target in many health system strategies to achieve the ‘good health and wellbeing’. Evidence on the meaning and scope of UHC and the strategies required to achieve it are needed, as variations in its understanding and implementation have risen. We synthesised evidence on the meaning, components, significance, and strategies of UHC. Methods: A review of evidence was conducted based on realist synthesis. We searched PubMed, EMBASE, Scopus, and Web of Science for published materials and websites for grey literature. We have followed some steps: define the scope of the review and develop initial programme theory, search for evidence, data extraction, and synthesis of evidence. Results: Universal coverage, universal health, universal healthcare, universal access, and insurance coverage are used interchangeably with UHC. It is a legal notion that embodies a human rights-based and collaborative approach to ensure fair and comprehensive health care services. Universal health coverage is relevant for three macro reasons: first, it prevents and reduces the impact of diseases; second, it addresses inequality and promotes equity; and third, it is key for global health security. Various mechanisms involved to implement UHC, such as health insurance, social health protection, digital financing systems, value-based care, private sectors, civil societies, partnership, primary health care, and reciprocal health care systems. Conclusions: Universal health coverage is a multifaceted concept that can be expressed by various terms in different contexts. Universal health coverage is a political and ethical imperative that aims to promote health equity and protect human dignity across different levels of society. It is essential in preventing diseases and serving a crucial role in global health security. Practically, UHC is not truly universal, as it does not include all services under its scheme and varies across countries. This requires consistent advocacy, strategic and operational research as well as political will to ensure UHC.

show abstract

Revisiting the role of civil society in responses to infectious disease outbreaks: a proposed framework and lessons from a COVID-19 vaccine equity coalition in Uganda

Cited by 2 publications

References 13 publications

Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics

Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics

Universal Health Coverage – Exploring the What, How, and Why Using Realistic Review

Contact Info

Product

Resources

About